VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $5,393,000 | -4.7% | 488,988 | +25.4% | 0.18% | +34.6% |
Q4 2016 | $5,660,000 | -50.5% | 389,796 | -16.3% | 0.13% | -42.9% |
Q3 2016 | $11,438,000 | +51.6% | 465,911 | +24.3% | 0.23% | +79.2% |
Q2 2016 | $7,547,000 | -53.0% | 374,737 | -38.6% | 0.13% | -54.1% |
Q1 2016 | $16,062,000 | -74.5% | 610,689 | -1.5% | 0.28% | -56.9% |
Q4 2015 | $63,028,000 | +59.2% | 620,056 | +179.4% | 0.66% | +73.1% |
Q3 2015 | $39,587,000 | -7.5% | 221,925 | +15.2% | 0.38% | -3.3% |
Q2 2015 | $42,813,000 | -11.4% | 192,720 | -20.8% | 0.39% | -18.5% |
Q1 2015 | $48,326,000 | -11.1% | 243,306 | -35.9% | 0.48% | +41.5% |
Q4 2014 | $54,360,000 | -21.5% | 379,840 | -28.0% | 0.34% | -0.9% |
Q3 2014 | $69,213,000 | +175.7% | 527,538 | +165.0% | 0.34% | +185.8% |
Q2 2014 | $25,105,000 | +52.7% | 199,054 | +59.6% | 0.12% | +31.9% |
Q1 2014 | $16,442,000 | -14.3% | 124,716 | -23.7% | 0.09% | -11.7% |
Q4 2013 | $19,183,000 | +23.3% | 163,399 | +9.6% | 0.10% | +7.3% |
Q3 2013 | $15,561,000 | +23.7% | 149,141 | +2.0% | 0.10% | +24.7% |
Q2 2013 | $12,582,000 | – | 146,169 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |